Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2017
Price : $35 *
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 13 Dec 2016 Status changed from active, no longer recruiting to completed.
- 27 May 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association (n = 9).